SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Exelixis, Inc. (EXEL) -- Ignore unavailable to you. Want to Upgrade?


To: rkrw who wrote (299)11/2/2006 6:40:24 PM
From: dr.praveen  Respond to of 930
 
Not much revealed today. They are going to look at the data and let us know between 2wks n 3 months. But most prob We might expect to hear from them before or at R&D day on Dec 4th.

They are trying to figure out the risk population, Risk benefit ratio and tinker with the dose, see if the SE profile is still acceptable....

One of the promising programs dented and we have to see if they can bring it on track successfully.